REFERENCES
- Allon N., Raveh L., Gilat E., Cohen E., Grunwald J., Ashani Y. Prophylaxis against soman inhalation toxicity in guinea pigs by pretreatment alone with human serum butyrylcholinesterase. Toxicol. Sci. 1998; 43: 121–128, [INFOTRIEVE], [CSA]
- Anthony J. S., Haley M., Manthei J., Way R., Burnett D., Gaviola B., Sommerville D., Crosier R., Mioduszewski R., Thomson S., Crouse C., Matson K. Inhalation toxicity of Cyclosarin (GF) vapor in rats as a function of exposure concentration and duration: Potency comparison to sarin (GB). Inhal. Toxicol. 2004; 16: 103–111, [INFOTRIEVE], [CROSSREF], [CSA]
- Anzueto A., de Lemos R. A., Seidenfeld J., Moore G., Hamil H., Johnson D., Jenkinson S. G. Acute inhalation toxicity of soman and sarin in baboons. Fundam. Appl. Toxicol. 1990; 14: 676–687, [INFOTRIEVE], [CROSSREF], [CSA]
- Bajgar J., Sevelova L., Krejcova G., Fusek J., Vachek J., Kassa J., Herink J., De Jong L. P., Benschop H. P. Biochemical and behavioral effects of soman vapors in low concentrations. Inhal. Toxicol. 2004; 16: 497–507, [INFOTRIEVE], [CROSSREF], [CSA]
- Benschop H. P., Trap H. C., Spruit H. E., van der Wiel H. J., Langenberg J. P., De Jong L. P. Low level nose-only exposure to the nerve agent soman: Toxicokinetics of soman stereoisomers and cholinesterase inhibition in atropinized guinea pigs. Toxicol. Appl. Pharmacol. 1998; 153: 179–185, [INFOTRIEVE], [CROSSREF], [CSA]
- Bide R. W., Risk D. J. Inhalation toxicity in mice exposed to sarin (GB) for 20–720 min. J. Appl. Toxicol. 2004; 24: 459–467, [INFOTRIEVE], [CROSSREF], [CSA]
- Bond J. A., Dahl A. R., Henderson R. F., Birnbaum L. S. Species differences in the distribution of inhaled butadiene in tissues. Am. Ind. Hyg. Assoc. J. 1987; 48: 867–872, [INFOTRIEVE], [CSA]
- Broomfield C. A., Kirby S. D. Progress on the road to new nerve agent treatments. J. Appl. Toxicol. 2001; 21(Suppl 1)S43–S46, [INFOTRIEVE], [CROSSREF], [CSA]
- Buchanan K. C., Burge R. R., Ruble G. R. Evaluation of injectable anesthetics for major surgical procedures in guinea pigs. Contemp. Top. Lab Anim Sci. 1998; 37: 58–63, [INFOTRIEVE], [CSA]
- Caranto G. R., Waibel K. H., Asher J. M., Larrison R. W., Brecht K. M., Schutz M. B., Raveh L., Ashani Y., Wolfe A. D., Maxwell D. M. Amplification of the effectiveness of acetylcholinesterase for detoxification of organophosphorus compounds by bis-quaternary oximes. Biochem. Pharmacol. 1994; 47: 347–357, [INFOTRIEVE], [CROSSREF], [CSA]
- Clark A. R. MDIs: Physics of aerosol formation. J. Aerosol Med. 1996; 9(Suppl 1)S19–S26, [INFOTRIEVE], [CSA]
- Clark A. R., Gonda I., Newhouse M. T. Towards meaningful laboratory tests for evaluation of pharmaceutical aerosols. J. Aerosol Med. 1998; 11(Suppl 1)S1–S7, [INFOTRIEVE], [CSA]
- Dabisch P. A., Burnett D. C., Miller D. B., Jakubowski E. M., Muse W. T., Forster J. S., Scotto J. A., Jarvis J. R., Davis E. A., Hulet S. W., Reutter S. A., Mioduszewski R. J., Thomson S. A. Tolerance to the miotic effect of sarin vapor in rats after multiple low-level exposures. J. Ocul. Pharmacol. Ther. 2005a; 21: 182–195, [INFOTRIEVE], [CROSSREF], [CSA]
- Dabisch P. A., Miller D. B., Reutter S. A., Mioduszewski R. J., Thomson S. A. Miotic tolerance to sarin vapor exposure: Role of the sympathetic and parasympathetic nervous systems. Toxicol. Sci. 2005b; 85: 1041–1047, [INFOTRIEVE], [CROSSREF], [CSA]
- Dacre J. C., Goldman M. Toxicology and pharmacology of the chemical warfare agent sulfur mustard. Pharmacol. Rev. 1996; 48: 289–326, [INFOTRIEVE], [CSA]
- DeLorenzo R. A. Exposed. Signs, symptoms & EMS management of nerve-agent poisoning. J Emerg. Med. Serv. JEMS. 2001; 26: 48–57, [INFOTRIEVE], [CSA]
- Ellman G. L., Courtney K. D., Andres V., Jr., Feather-Stone R. M. A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem. Pharmacol. 1961; 7: 88–95, [INFOTRIEVE], [CROSSREF], [CSA]
- Fok T. F., Monkman S., Dolovich M., Gray S., Coates G., Paes B., Rashid F., Newhouse M., Kirpalani H. Efficiency of aerosol medication delivery from a metered dose inhaler versus jet nebulizer in infants with bronchopulmonary dysplasia. Pediatr. Pulmonol. 1996; 21: 301–309, [INFOTRIEVE], [CROSSREF], [CSA]
- Hamilton M. G., Hill I., Conley J., Sawyer T. W., Caneva D. C., Lundy P. M. Clinical aspects of percutaneous poisoning by the chemical warfare agent VX: Effects of application site and decontamination. Mil. Med. 2004; 169: 856–862, [INFOTRIEVE], [CSA]
- Henderson R. F., Barr E. B., Blackwell W. B., Clark C. R., Conn C. A., Kalra R., March T. H., Sopori M. L., Tesfaigzi Y., Menache M. G., Mash D. C. Response of rats to low levels of sarin. Toxicol. Appl. Pharmacol. 2002; 184: 67–76, [INFOTRIEVE], [CROSSREF], [CSA]
- Holstege C. P., Kirk M., Sidell F. R. Chemical warfare. Nerve agent poisoning. Crit Care Clin. 1997; 13: 923–942, [INFOTRIEVE], [CROSSREF], [CSA]
- Jimmerson V. R., Shih T. M., Maxwell D. M., Kaminskis A., Mailman R. B. The effect of 2-(o-cresyl)-4H-1:3:2-benzodioxaphosphorin-2-oxide on tissue cholinesterase and carboxylesterase activities of the rat. Fundam. Appl. Toxicol. 1989a; 13: 568–575, [INFOTRIEVE], [CROSSREF], [CSA]
- Jimmerson V. R., Shih T. M., Maxwell D. M., Mailman R. B. Cresylbenzodioxaphosphorin oxide pretreatment alters soman-induced toxicity and inhibition of tissue cholinesterase activity of the rat. Toxicol. Lett. 1989b; 48: 93–103, [INFOTRIEVE], [CROSSREF], [CSA]
- Kadivar H., Adams S. C. Treatment of chemical and biological warfare injuries: Insights derived from the 1984 Iraqi attack on Majnoon Island. Mil. Med. 1991; 156: 171–177, [INFOTRIEVE], [CSA]
- Karalliedde L., Gauci C. A., Carter M. Chemical weapons. BMJ 1991; 302: 474, [INFOTRIEVE], [CSA]
- Karalliedde L., Wheeler H., Maclehose R., Murray V. Possible immediate and long-term health effects following exposure to chemical warfare agents. Public Health 2000; 114: 238–248, [INFOTRIEVE], [CROSSREF], [CSA]
- Kassa J., Koupilova M., Herink J., Vachek J. The long-term influence of low-level sarin exposure on behavioral and neurophysiological functions in rats. Acta Medica. (Hradec. Kralove) 2001; 44: 21–27, [CSA]
- Kassa J., Krejcova G., Skopec F., Herink J., Bajgar J., Sevelova L., Tichy M., Pecka M. The influence of sarin on various physiological functions in rats following single or repeated low-level inhalation exposure. Inhal. Toxicol. 2004a; 16: 517–530, [INFOTRIEVE], [CROSSREF], [CSA]
- Kassa J., Krocova Z., Sevelova L., Sheshko V., Kasalova I., Neubauerova V. The alteration of immune reactions in inbred BALB/c mice following low-level sarin inhalation exposure. Inhal. Toxicol. 2004b; 16: 509–515, [INFOTRIEVE], [CROSSREF], [CSA]
- Koping-Hoggard M., Issa M. M., Kohler T., Tronde A., Varum K. M., Artursson P. A miniaturized nebulization catheter for improved gene delivery to the mouse lung. J. Gene Med. 2005; 7: 1215–1222, [INFOTRIEVE], [CROSSREF], [CSA]
- Krondahl E., Tronde A., Eirefelt S., Forsmo-Bruce H., Ekstrom G., Bengtsson U. H., Lennernas H. Regional differences in bioavailability of an opioid tetrapeptide in vivo in rats after administration to the respiratory tract. Peptides 2002; 23: 479–488, [INFOTRIEVE], [CROSSREF], [CSA]
- Langenberg J. P., Spruit H. E., van der Wiel H. J., Trap H. C., Helmich R. B., Bergers W. W., van Helden H. P., Benschop H. P. Inhalation toxicokinetics of soman stereoisomers in the atropinized guinea pig with nose-only exposure to soman vapor. Toxicol. Appl. Pharmacol. 1998; 151: 79–87, [INFOTRIEVE], [CROSSREF], [CSA]
- Levy A., Chapman S., Cohen G., Raveh L., Rabinovitz I., Manistersky E., Kapon Y., Allon N., Gilat E. Protection and inflammatory markers following exposure of guinea pigs to sarin vapour: Comparative efficacy of three oximes. J. Appl. Toxicol. 2004; 24: 501–504, [INFOTRIEVE], [CROSSREF], [CSA]
- Maxwell D. M., Brecht K. M. The role of carboxylesterase in species variation of oxime protection against soman. Neurosci. Biobehav. Rev. 1991; 15: 135–139, [INFOTRIEVE], [CROSSREF], [CSA]
- Maxwell D. M., Brecht K. M., O'Neill B. L. The effect of carboxylesterase inhibition on interspecies differences in soman toxicity. Toxicol. Lett. 1987; 39: 35–42, [INFOTRIEVE], [CROSSREF], [CSA]
- Mioduszewski R., Manthei J., Way R., Burnett D., Gaviola B., Muse W., Thomson S., Sommerville D., Crosier R. Interaction of exposure concentration and duration in determining acute toxic effects of sarin vapor in rats. Toxicol. Sci. 2002; 66: 176–184, [INFOTRIEVE], [CROSSREF], [CSA]
- Munro N. Toxicity of the organophosphate chemical warfare agents GA, GB, and VX: Implications for public protection. Environ. Health Perspect. 1994; 102: 18–37, [INFOTRIEVE], [CSA]
- Newth C. J., Clark A. R. In vitro performance of the small particle aerosol generator (SPAG-2). Pediatr. Pulmonol. 1989; 7: 183–188, [INFOTRIEVE], [CSA]
- Pauluhn J., Mohr U. Inhalation studies in laboratory animals–current concepts and alternatives. Toxicol. Pathol. 2000; 28: 734–753, [INFOTRIEVE], [CSA]
- Ritter D., Knebel J., Aufderheide M. Comparative assessment of toxicities of mainstream smoke from commercial cigarettes. Inhal. Toxicol. 2004; 16: 691–700, [INFOTRIEVE], [CROSSREF], [CSA]
- Sevelova L., Vachek J., Bajgar J. Inhalation apparatus for generating sarin and soman toxic vapors. Acta Medica. (Hradec. Kralove) 2003b; 46: 157–161, [CSA]
- Sevelova L., Vachek J., Bajgar J. Inhalation apparatus for generating sarin and soman toxic vapors. Acta Medica. (Hradec. Kralove) 2003a; 46: 157–161, [CSA]
- Spruit H. E., Langenberg J. P., Trap H. C., van der Wiel H. J., Helmich R. B., van Helden H. P., Benschop H. P. Intravenous and inhalation toxicokinetics of sarin stereoisomers in atropinized guinea pigs. Toxicol. Appl. Pharmacol. 2000; 169: 249–254, [INFOTRIEVE], [CROSSREF], [CSA]
- Tronde A., Baran G., Eirefelt S., Lennernas H., Bengtsson U. H. Miniaturized nebulization catheters: A new approach for delivery of defined aerosol doses to the rat lung. J Aerosol Med. 2002; 15: 283–296, [INFOTRIEVE], [CROSSREF], [CSA]
- van Helden H. P., Kuijpers W. C., Diemel R. V. Asthmalike symptoms following intratracheal exposure of Guinea pigs to sulfur mustard aerosol: Therapeutic efficacy of exogenous lung surfactant curosurf and salbutamol. Inhal. Toxicol. 2004a; 16: 537–548, [INFOTRIEVE], [CROSSREF], [CSA]
- van Helden H. P., Vanwersch R. A., Kuijpers W. C., Trap H. C., Philippens I. H., Benschop H. P. Low levels of sarin affect the EEG in marmoset monkeys: A pilot study. J. Appl. Toxicol. 2004b; 24: 475–483, [INFOTRIEVE], [CROSSREF], [CSA]
- von der H. K., Kandler M. A., Popp K., Schoof E., Chada M., Rascher W., Dotsch J. Aerosolized adrenomedullin suppresses pulmonary transforming growth factor-beta1 and interleukin-1 beta gene expression in vivo. Eur. J. Pharmacol. 2002a; 457: 71–76, [CROSSREF], [CSA]
- von der H. K., Schoof E., Kandler M. A., Dotsch J., Rascher W. Aerosolized perfluorocarbon suppresses early pulmonary inflammatory response in a surfactant-depleted piglet model. Pediatr. Res. 2002b; 51: 177–182, [CSA]